Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals
Phase of Trial: Phase I
Latest Information Update: 30 May 2017
At a glance
- Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 07 Jun 2017 Biomarkers information updated
- 22 May 2017 Status changed from active, no longer recruiting to completed.
- 24 Oct 2016 Status changed from recruiting to active, no longer recruiting.